查詢結果分析
來源資料
相關文獻
- Progression of Hydroxychloroquine Retinopathy after Discontinuation of Therapy: Case Report
- 紅斑性狼瘡合併血小板缺乏病例討論
- Systemic Lupus Erythematosus Associated with Calcinosis Cutis--A Case Report and Review of the Literature
- 廣泛性毛囊缺陷瘤伴發於全身性紅斑性狼瘡
- Sex Differences in Pediatric Systemic Lupus Erythematosus: A Retrospective Analysis of 135 Case
- 水疱型全身性紅斑性狼瘡
- 紅斑性狼瘡合併肋膜積水
- 全身性紅斑性狼瘡
- 紅斑性狼瘡與妊娠之關係
- Influence of Infection on Prognosis of Systemic Lupus Erythematosus Patients Receiving Corticosteroid Treatment
頁籤選單縮合
題名 | Progression of Hydroxychloroquine Retinopathy after Discontinuation of Therapy: Case Report=停藥後Hydroxychloroquine網膜病變仍持續進行:病例報告 |
---|---|
作者姓名(中文) | 魏利真; 陳珊霓; 何正廉; 郭雅慧; 何昭德; | 書刊名 | 長庚醫學 |
卷期 | 24:5 2001.05[民90.05] |
頁次 | 頁329-334 |
分類號 | 415.695、415.695 |
關鍵詞 | 眼部副作用; 必賴克廔; 紅斑性狼瘡; Ocular side effect; Hydroxychloroquine; Systemic lupus erythematosus; |
語文 | 英文(English) |
英文摘要 | Chloroquine and its derivative, hydroxychloroquine sulfate, have been used in treating malaria, dermatitides of systemic lupus erythematosus and rheumatoid arthritis. Hydroxychloroquine retinopathy is uncommon in Taiwan. Here we report a patient with hydroxychloroquine retinopathy which progressed even after discontinuation of hydroxychloroquine. A 42-year-old woman had systemic lupus erythematosus for twenty years. She had been treated with 200 to 400 mg of hydroxychloroquine per day (4 to 8 mg/kg of body weight/day) with a cumulative dose of 657 g. After bull's-eye maculopathy was found, hydroxychloroquine was discontinued. Her medical history revealed no chloroquine administration and no other systemic disease. Five years after cessation of the therapy, her visual acuity and visual fields continued to deteriorate. Ophthalmoscopic examination revealed the hydroxychloroquine retinopathy had advanced. To the best of our knowledge, the progression of hydroxychloroquine retinopathy after discontinuation of medications is a rare phenomenon. Regular ophthalmologic examinations should be performed for patients on hydroxychloroquine regimens because there is no satisfactory treatment for hydroxychloroquine retinal toxicity. Ophthalmologists, dermatologists and rheumatologists should monitor for ocular toxicity of hydroxychloroquine carefully. (Chang Gung Med J 2001;24:329-34) |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。